Condition
Lead Exposure
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Not Yet Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07401251Not ApplicableNot Yet RecruitingPrimary
Lead Exposure Intervention Program
NCT05887934Enrolling By InvitationPrimary
Bone-Lead Level Associations With Brain and Mental Health
NCT04138693Not ApplicableCompletedPrimary
G-PUR® for Reduced Lead Bioavailability
NCT00342849Phase 3CompletedPrimary
Treatment of Lead-Exposed Children Trial
NCT00283647CompletedPrimary
MR Assessment of Brain Function Altered by Lead Exposure
Showing all 5 trials